Drug · DIN 02282283
MYLAN-RISPERIDONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 17, 2017; first marketed July 5, 2006.
- Drug Identification Number (DIN)
- 02282283
- Company (DIN owner)
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 5, 2009: NOC 10466Abbreviated New Drug Submission (ANDS) · Manufacturer and product name change
- July 5, 2006: NOC 8119Abbreviated New Drug Submission (ANDS)
Other DINs named MYLAN-RISPERIDONE
- DIN 02282240 · Cancelled Post Market
- DIN 02282259 · Cancelled Post Market
- DIN 02282267 · Cancelled Post Market
- DIN 02282275 · Cancelled Post Market
- DIN 02282291 · Cancelled Post Market